Thank you for working with me to optimize my treatment for hypothyroidism. My health improved so much since adding Cytomel that I began working with my Psychiatrist to titrate down, and hopefully off, my antidepressant. I have switched to 200 mg per day, taken in the morning and afternoon, instead of the timed release 300 mg pill.
I have not noticed any ill effects of reducing my levothyroxine dose to 150 mcg instead of 175. It would appear the Cytomel is "taking up the slack." And hopefully it will continue to take up the slack when I discontinue bupropion.
I am attaching a PDF copy of an article published in BMC Endocrine Disorders titled, "Time for a reassessment of the treatment for hypothyroidism." If you prefer to read it online, the link is bmcendocrdisord.biomedcentr...
The article points out:
"The interrelationship between TSH, free thyroxine (FT4) and free triiodothyronine (FT3) is patient specific and highly individual. Population-based statistical analysis is therefore subject to amalgamation problems (Simpson's paradox, collider stratification bias). This invalidates group-averaged and range-bound approaches, rather demanding a subject-related statistical approach."
and
"Studies relating TSH and thyroid hormone concentrations to adverse effects such as osteoporosis and atrial fibrillation invite similar caveats, as measuring TSH within the euthyroid range cannot substitute for FT4 and FT3 concentrations in the risk assessment. Direct markers of thyroid tissue effects and thyroid-specific quality of life instruments are required, but need methodological improvement."
Another good article on the subject is this one: frontiersin.org/articles/10...
Let me know if you need a PDF copy.